Skip to main content

Hemalkumar
B.
Mehta
,
PhD

Assistant Professor
Hemalkumar Mehta

Departmental Affiliations

Primary
Division
General Epidemiology and Methodology

Contact Info

615 N. Wolfe Street, Room E7640
Baltimore
Maryland
21205
US        

Research Interests

drug safety; drug effectiveness; pharmacoepidemiology; risk adjustment; comorbidity scores
Experiences & Accomplishments
Education
PhD
University of Houston
2014
MS
University of Houston
2010
BS
North Maharashtra University
2006
Overview
Dr. Mehta is a pharmacist with expertise in pharmaceutical health outcomes research. Dr. Mehta's research interests are in pharmacoepidemiology, comparative effectiveness research and risk adjustment. Dr. Mehta uses large administrative claims, electronic medical records and national survey data to determine drug utilization patterns and safety and effectiveness of pharmaceutical interventions.
Honors & Awards
Honors 2010 Inductee, Rho Chi Honor Society University of Houston Awards 2010 & 2011 Poster Finalist Award, 15th and 16th ISPOR annual meeting 2011 & 2012 Travel Grant and SAS Junior Professional Award, South Central SAS User’s Group (SCSUG) 2012 Travel Grant, 48th DIA annual meeting, Philadelphia, PA 2012 Travel Grant, 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), Barcelona, Spain 2014 Graduate Student Excellence Award, College of Pharmacy, University of Houston 2015 Certificate of Outstanding Contribution in Reviewing, Value in Health 2019 Top 10% reviewer, Annals of Internal Medicine
Select Publications
Selected publications:
  • Mehta HB, Mehta V, Girman CJ, Adhikari D, Johnson ML. Regression coefficient-based scoring system should be used to assign weights to the risk index. J Clin Epidemiol. 2016;79:22-28.
  • Mehta HB, Yong S, Sura SD, Hughes BD, Kuo YF, Williams SB, Tyler DS, Riall TS, Goodwin JS. Development of comorbidity score for patients undergoing major surgery. Health Serv Res. 2019.
  • Jupiter DC, Fang X, Ashmore Z, Shibuya N, Mehta HB. The Relative Risk of Achilles Tendon Injury in Patients Taking Quinolones. Pharmacotherapy. 2018;38(9):878-887.
  • Williams SB, Shan Y, Ray-Zack MD, Hudgins HK, Jazzar U, Tyler DS, Freedland SJ, Swanson TA, Baillargeon JG, Hu JC, Kaul S, Kamat AM, Gore JL, Mehta HB. Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer. JAMA Surg. 2019.